LY-295501

DB12574InvestigationalSmall molecule

ILX-295501 has been used in trials studying the treatment of Ovarian Cancer, Metastatic Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cavity Cancer.

Chemical structure of LY-295501
Formula / weight
C15H12Cl2N2O4S · 387.23 g/mol (avg)
Code names
ILX-295501 · LY295501

Resolves to

Compound
UNII240Y4YO0TNCAS150869-74-2ChEMBLCHEMBL307177PubChem127737
Structure
InChIKeyVAMFSFIPDOODFH-UHFFFAOYSA-NSMILESClC1=C(Cl)C=C(NC(=O)NS(=O)(=O)C2=CC=C3OCCC3=C2)C=C1
Targets
P13569CFTR

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-295501, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In